Biosimilars primer: What you need to know now
December 14, 2015|Internal Medicine
Author and Disclosure Information
EXPERT ANALYSIS FROM 2015 ADVANCES IN IBD
The meeting was sponsored by the Crohn’s & Colitis Foundation of America. Dr. Rubin has financial and consulting relationships with AbbVie, Janssen, Takeda, and numerous other pharmaceutical companies. Dr. Feagan has numerous relationships with pharmaceutical companies, including Abbott, Janssen, Teva, and others. Dr. Hanauer has served on the board of AbbVie and has financial relationships with numerous other pharmaceutical manufacturers. Dr. Regueiro did not have any disclosures relevant to this story.
On Twitter @whitneymcknight
This article was updated 1/6/16.
